Valuation in Life Sciences: A Practical Guide by Boris Bogdan (English) Hardcove

Description: Valuation in Life Sciences by Boris Bogdan, Ralph Villiger Valuation is a hot topic among life sciences professionals. FORMAT Hardcover LANGUAGE English CONDITION Brand New Publisher Description Valuation is a hot topic among life sciences professionals. There is no clear understanding on how to use the different valuation approaches and how to determine input parameters. Some do not value at all, arguing that it is not possible to get realistic and objective numbers out of it. Some claim it to be an art. In the following chapters we will provide the user with a concise val- tion manual, providing transparency and practical insight for all dealing with valuation in life sciences: project and portfolio managers, licensing executives, business developers, technology transfer managers, entrep- neurs, investors, and analysts. The purpose of the book is to explain how to apply discounted cash flow and real options valuation to life sciences p- jects, i.e. to license contracts, patents, and firms. We explain the fun- mentals and the pitfalls with case studies so that the reader is capable of performing the valuations on his own and repeat the theory in the exercises and case studies. The book is structured in five parts: In the first part, the introduction, we discuss the role of the players in the life sciences industry and their p- ticular interests. We describe why valuation is important to them, where they need it, and the current problems to it. The second part deals with the input parameters required for valuation in life sciences, i.e. success rates, costs, peak sales, and timelines. Notes This book offers a complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. After guiding the reader through the theory of valuation, including discounted cash-flow and real options, the authors demonstrate how to value projects, patents, licenses, firms and stocks on real-life examples, even treating complex license and company structures. Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results. Back Cover This book is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. After guiding the reader through the theory of valuation, including DCF, decision trees, and real options, the authors demonstrate how to value projects, patents, licences, firms, and stocks on real-life examples, even treating complex licence and company structures. Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results. The 3rd edition of the successful work includes new studies about success rates and about drug development in the biotech industry and their influence on valuation. Table of Contents Introduction.- The Life Sciences Industry.- Valuation.- Project Valuation.- License Contract Valuation.- Technology Valuation.- IP Valuation.- Firm Valuation.- Advanced Topics.- Valuation and Gut Feeling.- Excercises. Review From the reviews:"Valuation in Life Sciences: A Practical Guide leads readers step by step through the theory of life sciences valuation. … it is an important read for biotech investors. … It is the first book of its kind that combines industry data and valuation theory together with practical advice. It includes valuation techniques and tools that allow investors to pick undervalued biotech stocks." (GEN – genetic engineering news, February, 2007)"Valuation in Life Sciences: A Practical Guide opens up the black box and describes, step by step, a relatively simple procedure for quantitative valuation in life sciences. The book guides the reader through the recommended procedure of quantitative valuation … . This book is recommended to those who would like to acquire a profound understanding of quantitative valuation and use a simple spreadsheet approach of their own cases." (Rudolf Gygax, Nature Biotechnology, Vol. 25 (9), 2007)"This book provides some interesting examples – for business development and licensing executives – of where ROV may be used. … For the general reader and business development executive there is a good explanation of ROV and its applications in life science … . The book may also be of interest to biotechnology company business development executives and university technology transfer officers … . this book is essential reading as it not only provides the mathematical theory but also the applications in different types of deals." (Roger Davies, Business Development & Licensing Journal, Issue 4, 2007)From the reviews of the third edition:"The content and discussion contained in Valuation in Life Sciences is excellent. The Swiss authors provide a practical guide to what mathematical tools gives meaningful valuations … . Recommended for anyone planning to be involved in the development of a biotech venture." (C. Mathews, Amazon, December,2010)"The authors always keep the necessary rigour to make the book a valuable reference to professionals such as business developers, investment bankers, or analysts. … it an excellent textbook for students as well. … Valuation in Life Sciences addresses also the financial beginner with guided and easy-to-understand examples in Excel. I highly recommend the book to everyone in financial biotech." (Amazon, November, 2009)"This book is an excellent overview of business development valuation and great for those who want to catch up on some techniques and tools. It gives an accurate picture of BD in pharma. For those in the business … it remains a very valuable tool." (J. Serres, Amazon, March, 2009) Long Description Valuation is a hot topic among life sciences professionals. There is no clear understanding on how to use the different valuation approaches and how to determine input parameters. Some do not value at all, arguing that it is not possible to get realistic and objective numbers out of it. Some claim it to be an art. In the following chapters we will provide the user with a concise val- tion manual, providing transparency and practical insight for all dealing with valuation in life sciences: project and portfolio managers, licensing executives, business developers, technology transfer managers, entrep- neurs, investors, and analysts. The purpose of the book is to explain how to apply discounted cash flow and real options valuation to life sciences p- jects, i.e. to license contracts, patents, and firms. We explain the fun- mentals and the pitfalls with case studies so that the reader is capable of performing the valuations on his own and repeat the theory in the exercises and case studies. The book is structured in five parts: In the first part, the introduction, we discuss the role of the players in the life sciences industry and their p- ticular interests. We describe why valuation is important to them, where they need it, and the current problems to it. The second part deals with the input parameters required for valuation in life sciences, i.e. success rates, costs, peak sales, and timelines. Review Quote From the reviews:"Valuation in Life Sciences: A Practical Guide leads readers step by step through the theory of life sciences valuation. … it is an important read for biotech investors. … It is the first book of its kind that combines industry data and valuation theory together with practical advice. It includes valuation techniques and tools that allow investors to pick undervalued biotech stocks." (GEN genetic engineering news, February, 2007)"Valuation in Life Sciences: A Practical Guide opens up the black box and describes, step by step, a relatively simple procedure for quantitative valuation in life sciences. The book guides the reader through the recommended procedure of quantitative valuation … . This book is recommended to those who would like to acquire a profound understanding of quantitative valuation and use a simple spreadsheet approach of their own cases." (Rudolf Gygax, Nature Biotechnology, Vol. 25 (9), 2007)"This book provides some interesting examples for business development and licensing executives of where ROV may be used. … For the general reader and business development executive there is a good explanation of ROV and its applications in life science … . The book may also be of interest to biotechnology company business development executives and university technology transfer officers … . this book is essential reading as it not only provides the mathematical theory but also the applications in different types of deals." (Roger Davies, Business Development & Licensing Journal, Issue 4, 2007)From the reviews of the third edition:The content and discussion contained in Valuation in Life Sciences is excellent. The Swiss authors provide a practical guide to what mathematical tools gives meaningful valuations … . Recommended for anyone planning to be involved in the development of a biotech venture. (C. Mathews, Amazon, December, 2010)The authors always keep the necessary rigour to make the book a valuable reference to professionals such as business developers, investment bankers, or analysts. … it an excellent textbook for students as well. … Valuation in Life Sciences addresses also the financial beginner with guided and easy-to-understand examples in Excel. I highly recommend the book to everyone in financial biotech. (Amazon, November, 2009)This book is an excellent overview of business development valuation and great for those who want to catch up on some techniques and tools. It gives an accurate picture of BD in pharma. For those in the business … it remains a very valuable tool. (J. Serres, Amazon, March, 2009) Feature First complete guide to valuation in life sciences (pharma, biotech, medtech) Step-by-step explanation of how to practice valuation of projects and contracts With relevant data and many real-life examples and exercises Description for Sales People This book offers a complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. After guiding the reader through the theory of valuation, including discounted cash-flow and real options, the authors demonstrate how to value projects, patents, licenses, firms and stocks on real-life examples, even treating complex license and company structures. Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results. Details ISBN3642108199 Author Ralph Villiger Year 2010 ISBN-10 3642108199 ISBN-13 9783642108198 Format Hardcover Media Book Publication Date 2010-04-29 Edition 3rd Imprint Springer-Verlag Berlin and Heidelberg GmbH & Co. K Place of Publication Berlin Country of Publication Germany DEWEY 338.436151 Short Title VALUATION IN LIFE SCIENCES 3/E Language English Publisher Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Replaces 9783540782476 Pages 370 Subtitle A Practical Guide DOI 10.1007/978-3-642-10820-4 UK Release Date 2010-04-29 Illustrations XIV, 370 p. Edition Description 3rd ed. 2010 Alternative 9783642425844 Audience Professional & Vocational We've got this At The Nile, if you're looking for it, we've got it. With fast shipping, low prices, friendly service and well over a million items - you're bound to find what you want, at a price you'll love! TheNile_Item_ID:96249106;

Price: 174.5 AUD

Location: Melbourne

End Time: 2025-01-26T20:38:53.000Z

Shipping Cost: 23.03 AUD